18th March 2026
Victoria House, 37-63 Southampton Row, London, WC1B 4DR

Join MediWales on the 18th March 2026 for the annual BioWales in London conference in collaboration with the BIA, supported by Browne Jacobson and kindly hosted by Pioneer Group at Victoria House.

The Welsh life science sector is a thriving and dynamic ecosystem, particularly in the last few years, there have been significant developments around clinical innovation, medtech and diagnostics.

This event provides a unique platform for exciting new innovations and companies looking for investment and collaborations. With presentations from a variety of Welsh companies at various stages of their investor journey and an expert investor panel. We will also highlight NHS innovation and research collaboration opportunities, discussing clinical access, adoption and clinical trials.

The BioWales in London conference is kindly supported by Welsh Government and NHS Wales.

We have a limited number of sponsorship and exhibition opportunities available. If you would like to find out more or get involved in the programme, please contact us here.

_________________________________________________________

Draft programme

8:30am Registration

9:00am – Welcome presentations
Pioneer Group – Miranda Knaggs, Corporate Development Director
MediWales – Gwyn Tudor, CEO

Keynote presentations
MHRA – Samantha Coles, Deputy Director for Partnerships
Office for Life Sciences – Steve Bates, Executive Chair
BioIndustry Assocation – Jane Wall, Managing Director
Browne Jacobson – Gerard Hanratty, Head of Health and Life Sciences

NHS Health and Research Stream
Presentations from NHS Innovation Leads, leading research projects and collaborations with insights into innovation, adoption and procurement.

Welsh Government – Tom James, Head of Innovation Strategy and Policy, Life Sciences & Innovation Division
Hywel Dda University Health Board, Tritech Institute – Leighton Phillips, Director of Research, Innovation and Value, and Matthew Lawrence, Deputy Head of Innovation and Tritech
Digital Health and Care Wales – Rachael Powell, Associate Director of Information, Intelligence and Research
Betsi Cadwaladr University Health Board – Marie Latham-Jones, Technology Transfer Manager
Bangor University, North Wales Medical School – Dr Nia Jones, Deputy Head of Medical School
M-Sparc and Bangor University – Stef Thomas, Senior Lecturer
Life Sciences Hub Wales – Chris Jones, Project Lead – Economic Development

Panel discussion – Working with the NHS
Chaired by Welsh Government – Tom James, Head of Innovation Strategy and Policy, Life Sciences and Innovation Division
NHS Wales Joint Commissioning Committee – Rachel Gemine, Assistant Director of Information, Intelligence and Research
South West Wales Regional Joint Committee – Sion Charles, Head of Strategy and Service Planning
Tritech Institute – Matthew Lawrence, Deputy Head of Innovation and Tritech

12:30pm Lunch

Industry Stream – Technology Showcase and Future Watch
Company presentations highlighting the new innovations and developments from across health and life sciences.

Amotio – Iestyn Foster, CEO
Amotio is a medical technology company dedicated to advancing orthopaedic revision surgery through the development of a novel surgical device.
Ceryx Medical – Stuart Plant, CEO
Ceryx Medical are developing a new generation of medical devices based on their unique electronics technology. Their first product is a cardiac pacemaker specifically designed for the treatment of heart failure.
Molomix Bioscience – Stephen Pickett, CEO
Molomix Bioscience’s mission is to revolutionise genetic and molecular diagnostics by tackling the critical delays, costs, and risks of the traditional centralised lab model by deploying revolutionary “Lab-on-a-chip” platforms directly to the point of care.
Astral Automation Solutions – Simon Smith, Co-Founder
Astral Automation is a next-gen lab automation system integrator building a vendor-agnostic whole-lab platform that unifies the Make and Test steps of the DTMA cycle and enables rapid, low-risk rollout of scalable automation.
MeOmics – Lucy Sykes, CEO
MeOmics is creating a new way to discover psychiatric drugs by growing human brain cells from the patient population. They measure electrical activity and harness AI to understand how patient brain cells signal and respond to treatments.
Jellagen – Andrew Mearns-Spragg, Founder and Chief Scientific Officer
Jellagen is a MedTech business manufacturing next generation collagen products sourced from jellyfish for application in 2D and 3D cell culture and medical devices.
CanSense – Adam Bryant, CEO
CanSense sets out to change peoples lives through the early detection of bowel cancer utilising spectroscopy and AI technologies on a standard blood draw.
Biophys – Michael Graz, Founder and Chief Scientific Officer
Biophys is a consortium of leadership, management and technical experts with experience in leading, growing and finding solutions in life science, medtech and novel food organisations.
Carevanta – Victoria Wilbraham, CEO
Carevanta is the first intelligence platform that enables healthcare systems and suppliers to design care pathways and measure the real-world impact of change.
éclateral – Paul Ko Ferrigno, CEO
éclateral’s mission is to deliver low cost, accessible, clinical grade and digitally connected diagnostic tests in people’s homes.

Investor Panel
Q&A and discussion with life science investors.

Chaired by BioIndustry Association – Martin Turner, Director of Policy and External Affairs
SV Health Ventures – Charles Dunn, Principal
SFC Capital – Jason Druker, Chief Commercial Officer
NLC Health Ventures – Ileana Lindeman, Partner
Development Bank of Wales – Jack Christopher, Investment Executive

Japan roundtable collaboration discussion
Wales has had a long standing, close relationship with Japan since Japanese companies made their first investments in manufacturing in Wales in the 1970s. During the year of Japan and Wales in 2025, we celebrated and strengthened these relationships and stimulated new economic partnerships within the life sciences sector.

Chaired by MediWales – Gwyn Tudor, CEO
Welsh Government – Julie Russell, Business Development Manager – Inward Investment
Fujifilm – Huw Shurmer, Strategic and Government Relationship Manager
Japan Agency for Medical Research and Development – Kenichiro Watanabe, Director
JETRO – Hideo Yura, Director General
NHS South West Wales Regional Joint Committee – Sion Charles, Regional Head of Strategy and Service Planning
Sony UK Technology Centre – Joe Whaley, Senior Manager of Business Development

__________________________________________________

Costs

MediWales members and invited guests – Free

Non members – £150 + VAT

Partner organisations (SEHTA, OBN, Medilink UK, BIA, BioPartner, ABHI, One Nucleus, Pioneer) – Discounted rate of £95 + VAT

There are a limited number of complimentary spaces available for start ups and SMEs, please get in touch if you would like to attend.

_________________________________________________________

If you would like to register for day 2 – the BioWales in London conference, please click here.

If you would like to register for the BioWales Investor Networking: Investing in the Future of Health – day 1 of BioWales in London, please click here.